Archer Daniels Midland Company (ADM) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
8 Jul, 2026Executive summary
Q3 2024 adjusted EPS was $1.09, down 33% year-over-year, with net earnings of $18M and a $461M Wilmar impairment charge; YTD adjusted EPS was $3.61 and segment operating profit $3.2B.
Total segment operating profit for Q3 was $1.0B, down 28% year-over-year; YTD was $3.2B, down 32% year-over-year.
Cash flow from operations before working capital was $2.3B YTD, down 39% from prior year; operating cash flow YTD was $2.5B, up from $1.9B in the prior year period.
$3.1B returned to shareholders YTD: $744M in dividends and $2.3B in share repurchases.
Restated financials for 2023 and early 2024 had no impact on consolidated results; internal control weaknesses persist.
Financial highlights
Q3 2024 revenues were $19.9B, down 8% year-over-year; YTD revenues were $64.0B, down from $71.0B.
Q3 2024 net earnings attributable to ADM were $18M ($0.04 per share), down from $821M ($1.52 per share) in Q3 2023.
Asset impairment, exit, and restructuring costs rose to $507M, mainly from the Wilmar investment write-down.
Gross profit declined 25% to $1.4B; Q3 2024 gross margin was 6.8%, down from 8.3% in Q3 2023.
Adjusted EBITDA for the trailing four quarters was $4.7B.
Outlook and guidance
Full-year 2024 adjusted EPS guidance lowered to $4.50–$5.00 per share, reflecting ongoing market headwinds and operational challenges.
Corporate cost guidance set at $1.7B–$1.8B; capital expenditures expected at ~$1.5B; effective tax rate 20%–22%.
Q4: Ag Services & Oilseeds results expected significantly lower vs. prior year; Carbohydrate Solutions in line; Nutrition lower sequentially but higher than Q4 2023.
Insurance proceeds of $50M–$135M expected in Q4 for Decatur incidents, with further payments into 2025–2026.
Adjusted net debt/adjusted EBITDA expected at 1.5x–2.0x; actual YTD is 1.9x.
Latest events from Archer Daniels Midland Company
- Strong earnings, cost discipline, and innovation drive growth amid regulatory clarity and market expansion.ADM
Barclays 18th Annual Global Consumer Staples Conference 20258 Jul 2026 - Raised 2026 EPS guidance as strong ethanol and nutrition offset oilseeds headwinds.ADM
Q1 202611 May 2026 - All board proposals passed; strong financials and strategic growth initiatives highlighted.ADM
AGM 20269 May 2026 - 2026 EPS guidance raised as cost savings and cash flow support growth despite 2025 declines.ADM
Q4 202513 Apr 2026 - Operational strength, innovation, and policy tailwinds drive growth amid shifting market dynamics.ADM
Bank of America 2026 Global Agriculture and Materials Conference9 Apr 2026 - Key votes include director elections, executive pay, auditor ratification, and ESG reporting.ADM
Proxy filing26 Mar 2026 - Cost savings, decarbonization, and governance drive value; Board opposes new pesticide reporting.ADM
Proxy filing26 Mar 2026 - Earnings and margins fell, but capital returns and full-year EPS guidance held steady.ADM
Q2 20242 Feb 2026 - Growth outlook remains robust, with cost savings, automation, and Nutrition gains driving performance.ADM
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026